State Medicaid Drug Selection Panels' Conflict-Of-Interest Policies Vary Widely

Kaiser Health News

State policies to ensure drug selection in Medicaid programs is free from outside influence vary widely, according to a new study. MedPage Today: Medicaid Drug Panel Conflict Policies Vary Widely. There's little consistency among conflict-of-interest (COI) policies for state Medicaid drug selection committees, researchers found. Researchers could obtain such policies for only 27 states, and the principles governing these documents varied greatly, according to Nicole Yvonne Nguyen, PharmD, and Lisa Bero, PhD, of the University of California San Francisco. While two-thirds mandated disclosure of conflicts, for instance, fewer than half set monetary cutoffs for reporting, or required that disclosures be publicly available, they wrote online in JAMA Internal Medicine.

State Medicaid Drug Selection Panels' Conflict-Of-Interest Policies Vary Widely